Ultragenyx Pharmaceutical Inc. <RARE.O>: JP Morgan Cuts to Neutral From Overweight; Cuts Target Price to $36 From $80
RARE•Related News
C1 Fund Inc <CFND.N>: StoneX initiates coverage with buy rating; target price $6
CFND•
India Stocks-Financials lead Indian shares higher after recent decline
XLF•
HBIS, Nio seek deeper supply-chain collaboration, new materials development
NIO•
Uber cuts workforce about 10% in corporate reorganization
UBER•
NexGen Energy Ltd. <NXE.TO>: Jefferies initiates coverage with buy rating; target price C$21
NXE•